PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Real-World Experience With Janus Kinase Inhibitors in the Treatment of Advanced Ulcerative Colitis: What Does the Evidence Say?
Visit https://www.peervoice.com/QPW860 to view the entire programme with slides. After completing “John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Real-World Experience With Janus Kinase Inhibitors in the Treatment of Advanced Ulcerative Colitis: What Does the Evidence Say?”, participants will be able to: Discuss the safety and efficacy of JAK inhibitors and their real-world evidence in the treatment of advanced ulcerative colitis; and Apply strategies to tailor therapy selection for patients with advanced ulcerative colitis using JAK inhibitors.